NSE: UNICHEMLAB

Unichem Laboratories Ltd Share Price

Company information and financial fundamentals for Unichem Laboratories Ltd, alongside its latest NSE share price.

Last price₹507.20+3.76% today · prev close ₹488.80
SectorHealthcare

About Unichem Laboratories Ltd

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.[1]

Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals · NSE symbol: UNICHEMLAB

Company fundamentals

Market Cap₹ 3,566 Cr.
Current Price₹ 506
High / Low₹ 687 / 278
Stock P/E29.2
Book Value₹ 386
Dividend Yield0.00 %
ROCE4.13 %
ROE3.17 %
Face Value₹ 2.00

Figures are as reported by the company and compiled by screener.in (fetched 2026-11-03); they may lag the latest filing. Educational information, not investment advice.

Quarterly results (₹ crore)

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales432483507533587527579521575633
Expenses406443452448503504513476527563
Operating Profit25405586842266454870
OPM %6%8%11%16%14%4.3%11%9%8%11%
Other Income-119491497-372871116
Interest5457578797
Depreciation27323231303231313130
Profit before tax-1268276258-9-112931949
Tax %3%74%9%6%8%16%10%10%42%15%
Net Profit-1292255853-10-122641141
EPS in Rs-18.370.293.508.227.52-1.49-1.6937.541.555.89
Raw PDF——————————

Profit and loss, yearly (₹ crore)

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8151,1801,1041,2351,2701,3431,7852,1112,2022,308
Expenses9421,2541,1531,1441,1981,3891,6981,8462,0132,079
Operating Profit-128-74-499172-4687265189229
OPM %-16%-6%-4.5%7%6%-3.4%4.9%13%9%10%
Other Income2,73591915047-0-2635260277
Interest888561723213232
Depreciation5167828491113123125125123
Profit before tax2,548-58-485122-176-85155292350
Tax %0%-59%25%33%-50%15%10%11%14%—
Net Profit2,545-24-603433-202-94138253305
EPS in Rs361.82-3.38-8.554.874.70-28.72-13.3219.5335.9143.29
Dividend Payout %1%-118%-47%82%85%-14%0%0%0%—

Compounded growth

Compounded Sales Growth10 Years 5%5 Years 12%3 Years 18%TTM 7%
Compounded Profit Growth10 Years -3%5 Years 25%3 Years 35%TTM -2%
Stock Price CAGR10 Years 6%5 Years 18%3 Years 8%1 Year 6%
Return on Equity10 Years 11%5 Years 0%3 Years 2%Last Year 3%

Balance sheet (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital18141414141414141414
Reserves1,0452,6662,6062,5172,5432,6042,4212,4242,4372,703
Borrowings98151200206119349314248460500
Other Liabilities359359323407436351444589659489
Total Liabilities1,5213,1903,1423,1453,1123,3193,1933,2753,5693,707
Fixed Assets4915788108708849901,2571,2521,3001,213
CWIP2502389233056849414712331100
Investments149019265503922642100
Other Assets7661,4731,3131,3951,2691,5711,7871,8982,2392,394
Total Assets1,5213,1903,1423,1453,1123,3193,1933,2753,5693,707

Cash flows (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity68-112-3282033-260-8514-74
Cash from Investing Activity-1321,648-286-36-6610024163-242194
Cash from Financing Activity59-881-2-62-121191-81-1061842
Net Cash Flow-4655-616-78-1543275-29-65200
Free Cash Flow-79-271-519-360-254-386-1230-142163
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit-237%89%424%-49%52%-350%160%23%4%6%

Efficiency ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days16512413512974142160131135137
Inventory Days397278278374518527414365418349
Days Payable297230182236202161193174164128
Cash Conversion Cycle265172231267390508382322389358
Working Capital Days174133165154163207207173159169
ROCE %9%128%-2%-2%2%1%-5%-0%6%4%

Shareholding pattern (%)

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%70.22%
FIIs0.89%0.94%1.05%0.98%0.98%0.99%0.99%1.00%0.90%2.70%
DIIs11.57%11.65%11.63%11.32%10.92%10.74%10.73%10.63%10.46%9.40%
Public17.32%17.17%17.11%17.47%17.88%18.04%18.05%18.14%18.41%17.67%
No. of Shareholders20,62120,37421,47221,62123,01023,57723,26723,38625,34726,164

Exchange disclosures

Next results date

Unichem Laboratories Ltd has a board meeting for financial results listed on 2026-11-04. Companies can reschedule; check the company's own announcement. Results calendar

Shown as filed with NSE. A filing shows that something happened, not why, and says nothing about what to do.

Compare UNICHEMLAB with APOLLOHOSP →

Wondering what to do with Unichem Laboratories Ltd?

This page shares company information and reported fundamentals. It does not tell you whether to buy, hold or sell. For a view that takes your own holding and goal into account, ask Samjho Bhai, our portfolio review tool.

Ask Samjho Bhai about UNICHEMLAB →

How this page works · New to company fundamentals? Start learning.

Key terms: Nifty 50 · Price-to-earnings ratio · Earnings per share · Dividend yield · Market capitalisation

Other Healthcare stocks in the NSE

Apollo HospitalsNSE: APOLLOHOSPCiplaNSE: CIPLADr. Reddy's LaboratoriesNSE: DRREDDYMax HealthcareNSE: MAXHEALTHSun PharmaNSE: SUNPHARMA

Frequently asked questions

What is the NSE symbol for Unichem Laboratories Ltd?

Unichem Laboratories Ltd trades on the NSE under the symbol UNICHEMLAB.

Where is Unichem Laboratories Ltd listed?

Unichem Laboratories Ltd is listed on the National Stock Exchange of India (NSE) under the symbol UNICHEMLAB. It is not part of the NIFTY 50 or NIFTY 500 lists this site tracks.

Should I buy Unichem Laboratories Ltd shares?

Market Dekho does not give buy, sell or hold recommendations and is not a SEBI-registered Research Analyst or Investment Adviser. To review a holding against your own goal and risk, you can use Samjho Bhai, or speak to a SEBI-registered adviser.

Prices are delayed and sourced from a public market-data provider; they may contain errors. This page is educational information, not investment advice.